Association of -1112 C/T promoter region polymorphism of the interleukin 13 gene with occurrence of colorectal cancer

Polski Przeglad Chirurgiczny/ Polish Journal of Surgery

Volumn 83, Issue 1, 2011, Pages 27-31

  Walczak, Anna ^a   Przybyłowska, Karolina ^a   Trzciński, Radzisław ^a   Sygut, Andrzej ^a   Dziki, Łukasz ^a   Dziki, Adam ^a   Majsterek, Ireneusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

colorectal cancer; cytokines; IL 13 gene polymorphism

Indexed keywords

INTERLEUKIN 13;

ADULT; ARTICLE; CAUCASIAN; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; POLAND; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-13; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 79952830839     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-011-0004-x     Document Type: Article

References (14)

1. Raporty na podstawie danych Centrum Onkologii -
2. Kemp Z, Thirlwell C, Sieber O et al.: An update on the genetics of colorectal cancer. Hum Mol Genet 2004; 13, 177-85.
3. Minty A, Ferrara P, Caput D: Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma. Eur Cytokine Netw 1997; 8: 189-201.
4. Hajoui O, Janani R, Tulic M et al.: Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production. J Allergy Clin Immunol 2004; 114: 657-63.
5. Endo Y, Marusawa H, Kou T et al.: Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology 2008; 135: 889-98.
6. Rothenberg ME: Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009; 137: 1238-49.
7. Formentini A, Prokopchuk O, Sträter J et al.: Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases. Int J Colorectal Dis 2009; 24: 57-67.
8. Faghih Z, Erfani N, Razmkhah M et al.: Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer. Mol Biol Rep 2009; 36: 1923-28.
9. Sameni S, Ghayumi MA, Mortazavi G et al.: Lack of association between interleukin-13 gene polymorphisms (-1055 C/T and +2044 G/A) in Iranian patients with lung cancer. Mol Biol Rep 2009; 36: 1001-05.
10. Schwartzbaum JA, Ahlbom A, La¶nn S et al.: M. An international case-control study of interleukin- 4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev 2007; 16: 2448-54.
11. Mandal D, Levine AD: Elevated IL-13 Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway. Inflamm Bowel Dis 2010; 16: 753-64.
12. Murata T, Noguchi PD, Puri RK: IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J Immunol 1996; 156: 2972-78.
13. Kanai T, Watanabe M, Hayashi A et al.: Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion. Br J Cancer 2000; 82: 1717-23.
14. Trejdosiewicz LK, Morton R, Yang Y et al.: Interleukins 4 and 13 upregulate expression of cd44 in human colonic epithelial cell lines. Cytokine 1998; 10: 756-65.